These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8962979)

  • 21. LMP2 polymorphism is associated with extraspinal disease in HLA-B27 negative Caucasian and Mexican Mestizo patients with ankylosing spondylitis.
    Maksymowych WP; Tao S; Vaile J; Suarez-Almazor M; Ramos-Remus C; Russell AS
    J Rheumatol; 2000 Jan; 27(1):183-9. PubMed ID: 10648037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to nitrogenase-positive and -negative Klebsiella pneumoniae strains in juvenile-onset ankylosing spondylitis patients and their first degree relatives: lack of differential recognition of the bacterial nitrogenase.
    Parra-Campos V; Escobar-Gutiérrez A; Domínguez-López ML; Cancino-Díaz M; Burgos-Vargas R; Granados-Arreola J; Jiménez-Zamudio L; García-Latorre E
    Rev Latinoam Microbiol; 1996; 38(2):121-7. PubMed ID: 8986112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-B27-restricted CD8+ T cell response to cartilage-derived self peptides in ankylosing spondylitis.
    Atagunduz P; Appel H; Kuon W; Wu P; Thiel A; Kloetzel PM; Sieper J
    Arthritis Rheum; 2005 Mar; 52(3):892-901. PubMed ID: 15751060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-B27 in the Greek Cypriot population: distribution of subtypes in patients with ankylosing spondylitis and other HLA-B27-related diseases. The possible protective role of B*2707.
    Varnavidou-Nicolaidou A; Karpasitou K; Georgiou D; Stylianou G; Kokkofitou A; Michalis C; Constantina C; Gregoriadou C; Kyriakides G
    Hum Immunol; 2004 Dec; 65(12):1451-4. PubMed ID: 15603872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA B27 prevalence in spondylo-arthropathy syndromes.
    Dequeker J; Decock T; Walravens M; van de Putte I
    Acta Rhumatol; 1979; 3(2):144-53; discussion 153-5. PubMed ID: 11496652
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histiocytosis syndrome (histiocytosis X) in infancy].
    Török E; Király L; Walcz E
    Orv Hetil; 1984 Oct; 125(43):2611-4. PubMed ID: 6387584
    [No Abstract]   [Full Text] [Related]  

  • 27. [Painful edema of the feet revealing ankylosing spondylitis].
    Marquart-Elbaz C; Lipsker D; Sibilia J; Faivre M; Grosshans E; Cribier B
    Ann Dermatol Venereol; 2002; 129(6-7):889-91. PubMed ID: 12218918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Association of HLA molecules with autoimmune diseases].
    Kolostová K; Cerná M; Andĕl M
    Cas Lek Cesk; 2002 Dec; 141(24):755-62. PubMed ID: 12661465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ankylosing spondylitis and heterogenity of HLA-B27 in Chinese].
    Lin J; Lu H; Feng C
    Zhonghua Wai Ke Za Zhi; 1996 Jun; 34(6):333-5. PubMed ID: 9594171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.
    Nicknam MH; Mahmoudi M; Amirzargar AA; Ganjalikhani Hakemi M; Khosravi F; Jamshidi AR; Amirkhani A; Ansaripour B; Pourpak Z; Moin M; Nikbin B
    Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):19-24. PubMed ID: 18322308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ankylosing spondylarthritis].
    Hubault A
    Rev Prat; 1982 Dec; 32(59-60):3725-33. PubMed ID: 6298925
    [No Abstract]   [Full Text] [Related]  

  • 32. Usefulness of human leucocyte antigen-B27 subtypes in predicting ankylosing spondylitis: Taiwan experience.
    Hou TY; Chen HC; Chen CH; Chang DM; Liu FC; Lai JH
    Intern Med J; 2007 Nov; 37(11):749-52. PubMed ID: 17908086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory IL4+CD8+ T cells in patients with ankylosing spondylitis and healthy controls.
    Zhang L; Jarvis LB; Baek HJ; Gaston JS
    Ann Rheum Dis; 2009 Aug; 68(8):1345-51. PubMed ID: 18647857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis.
    Monnet D; Moachon L; Dougados M; Brézin AP
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):393-7. PubMed ID: 16932725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Variation in HLA-B27 gene subtypes and susceptibility of ankylosing spondylitis in the Croatian population].
    Grubić Z; Kerhin-Brkljacić V; Perić P; Cecuk E; Kastelan A
    Reumatizam; 2001; 48(1):7-11. PubMed ID: 12476735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic aspects of ankylosing spondylitis.
    Khan MA; Ball EJ
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):675-90. PubMed ID: 12406434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-B27 and ankylosing spondylitis geographic distribution as the result of a genetic selection induced by malaria endemic? A review supporting the hypothesis.
    Mathieu A; Cauli A; Fiorillo MT; Sorrentino R
    Autoimmun Rev; 2008 May; 7(5):398-403. PubMed ID: 18486928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of a population of HLA-B27-positive blood donors].
    Devogelaer JP; Huaux JP; De Bruyere M; Maldague B; Nagant de Deuxchaisnes C
    Acta Rhumatol; 1979; 3(2):110-20. PubMed ID: 11496649
    [No Abstract]   [Full Text] [Related]  

  • 39. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis.
    Marcilla M; López de Castro JA
    Tissue Antigens; 2008 Jun; 71(6):495-506. PubMed ID: 18489433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenesis of Bechterew disease].
    Gran JT
    Tidsskr Nor Laegeforen; 1998 Nov; 118(29):4537-40. PubMed ID: 9889641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.